Connection
Peter Kabos to Maximum Tolerated Dose
This is a "connection" page, showing publications Peter Kabos has written about Maximum Tolerated Dose.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.054 |
|
|
|
-
Hamilton E, Oliveira M, Turner N, Garc?a-Corbacho J, Hernando C, Ciruelos EM, Kabos P, Ruiz-Borrego M, Armstrong A, Patel MR, Vaklavas C, Twelves C, Boni V, Incorvati J, Brier T, Gibbons L, Klinowska T, Lindemann JPO, Morrow CJ, Sykes A, Baird RD. A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results. Ann Oncol. 2024 Aug; 35(8):707-717.
Score: 0.054